Public Health Emergency Management, Ethiopia Public Health Institute, Addis Ababa, Ethiopia.
Clinical, Assessment, Regulatory, and Evaluation Unit, International Vaccine Institute, Seoul, Republic of Korea.
Clin Infect Dis. 2024 Jul 12;79(Supplement_1):S1-S7. doi: 10.1093/cid/ciae200.
Cholera remains a significant public health concern in Ethiopia. More than 15.9 million Ethiopians, constituting 15% of the total population, live in areas with a history of recurrent cholera outbreaks. The last 9 years of national cholera surveillance data show the country has been experiencing cholera outbreaks every year. The current cholera outbreak, starting in August 2022, has affected the entire country, with 841 reported cases and a 3.13% case fatality rate (CFR) in 2022, and >30 000 cases with nearly a 1.4% CFR in 2023. In line with "Ending Cholera-A Global Roadmap to 2030," the government of Ethiopia is committed to eliminate cholera in the country and has prepared its "National Cholera Elimination Plan (NCP): 2022-2028" with aims to achieve zero local transmission in cholera hotspot areas by 2028 and 90% fatality reduction from the recent (2020-2022) average of 1.8% CFR. The plan is multisectoral, has a clear coordination platform, contains all interventions with in-depth situational analysis, is concordant with existing plans and strategies, and is cascaded at the regional level and implemented with existing government and public structures. Nationwide, total 118 cholera hotspot woredas (districts) were identified, and a comprehensive situation analysis of the existing cholera outbreak response capacity was assessed. This multisectoral and multiyear NCP has forecasted around US$404 million budget estimates with >90% allocated to improving the country's water, sanitation, and hygiene (US$222 million; 55% of total NCP budget) and case management (US$149 million; 37%). The cholera vaccination strategy included in the NCP exhibited a 5-year oral cholera vaccine (OCV) introduction plan with 2 doses (30 604 889 doses) and single dose (3 031 266 doses) in selected cholera hotspot areas. However, its implementation is challenged due to a lack of financial support, inability to get the requested vaccine for targeted hotspot woredas (due to the current shortage of doses in the OCV global stockpile), recurrent cholera outbreaks, and high humanitarian needs in the country. It is recommended to have a sustainable financial mechanism to support implementation, follow the requested vaccine doses, and reorganize the planned coordination platform to foster the implementation.
霍乱仍然是埃塞俄比亚的一个重大公共卫生问题。超过 1590 万埃塞俄比亚人,占总人口的 15%,生活在反复发生霍乱疫情的地区。过去 9 年的国家霍乱监测数据显示,该国每年都在发生霍乱疫情。自 2022 年 8 月开始的当前霍乱疫情已影响到全国,2022 年报告了 841 例病例,病死率为 3.13%(CFR),2023 年报告了超过 3 万例病例,病死率接近 1.4%。根据《终结霍乱-全球路线图至 2030 年》,埃塞俄比亚政府致力于在该国消除霍乱,并已制定了其《国家霍乱消除计划(NCP):2022-2028》,目标是到 2028 年在霍乱热点地区实现零本地传播,并将最近(2020-2022 年)1.8%的 CFR 平均病死率降低 90%。该计划是多部门的,有明确的协调平台,包含所有干预措施的深入情况分析,与现有计划和战略一致,并在区域一级进行分层,并利用现有的政府和公共结构来实施。在全国范围内,共确定了 118 个霍乱热点沃里德(区),并对现有的霍乱疫情应对能力进行了全面情况分析。这个多部门和多年的 NCP 预测预算约为 4.04 亿美元,其中 90%以上用于改善该国的水、环境卫生和个人卫生(2.22 亿美元;占 NCP 总预算的 55%)和病例管理(1.49 亿美元;占 37%)。NCP 中包含的霍乱疫苗接种战略展示了一项为期 5 年的口服霍乱疫苗(OCV)引入计划,在选定的霍乱热点地区接种 2 剂(30604889 剂)和 1 剂(3031266 剂)。然而,由于缺乏财政支持、无法获得目标热点沃里德所需的疫苗(由于 OCV 全球库存目前短缺剂量)、霍乱疫情反复发生以及该国人道主义需求高,该计划的实施面临挑战。建议建立可持续的财政机制来支持实施,遵循所需的疫苗剂量,并重新组织计划中的协调平台,以促进实施。